These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 21112353)
1. Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates. Verina T; Kiihl SF; Schneider JS; Guilarte TR Neurotoxicology; 2011 Mar; 32(2):215-26. PubMed ID: 21112353 [TBL] [Abstract][Full Text] [Related]
2. Acute and chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys. Vázquez-Claverie M; Garrido-Gil P; San Sebastián W; Izal-Azcárate A; Belzunegui S; Marcilla I; López B; Luquin MR J Neuropathol Exp Neurol; 2009 Sep; 68(9):977-84. PubMed ID: 19680145 [TBL] [Abstract][Full Text] [Related]
3. Intranasal administration of α-synuclein preformed fibrils triggers microglial iron deposition in the substantia nigra of Macaca fascicularis. Guo JJ; Yue F; Song DY; Bousset L; Liang X; Tang J; Yuan L; Li W; Melki R; Tang Y; Chan P; Guo C; Li JY Cell Death Dis; 2021 Jan; 12(1):81. PubMed ID: 33441545 [TBL] [Abstract][Full Text] [Related]
4. Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure. Barcia C; Sánchez Bahillo A; Fernández-Villalba E; Bautista V; Poza Y Poza M; Fernández-Barreiro A; Hirsch EC; Herrero MT Glia; 2004 May; 46(4):402-9. PubMed ID: 15095370 [TBL] [Abstract][Full Text] [Related]
5. Inflammatory reaction regulated by microglia plays a role in atrazine-induced dopaminergic neuron degeneration in the substantia nigra. Zhang B; Ma K; Li B J Toxicol Sci; 2015 Aug; 40(4):437-50. PubMed ID: 26165640 [TBL] [Abstract][Full Text] [Related]
6. Persistent phagocytic characteristics of microglia in the substantia nigra of long-term Parkinsonian macaques. Barcia C; Ros CM; Ros-Bernal F; Gómez A; Annese V; Carrillo-de Sauvage MA; Yuste JE; Campuzano CM; de Pablos V; Fernández-Villalba E; Herrero MT J Neuroimmunol; 2013 Aug; 261(1-2):60-6. PubMed ID: 23759319 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice. Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781 [TBL] [Abstract][Full Text] [Related]
8. Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Yasuda Y; Shinagawa R; Yamada M; Mori T; Tateishi N; Fujita S Brain Res; 2007 Mar; 1138():196-202. PubMed ID: 17275793 [TBL] [Abstract][Full Text] [Related]
9. Manganese exposure in juvenile C57BL/6 mice increases glial inflammatory responses in the substantia nigra following infection with H1N1 influenza virus. Bantle CM; French CT; Cummings JE; Sadasivan S; Tran K; Slayden RA; Smeyne RJ; Tjalkens RB PLoS One; 2021; 16(1):e0245171. PubMed ID: 33493177 [TBL] [Abstract][Full Text] [Related]
10. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
11. Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism. Guilarte TR; Burton NC; McGlothan JL; Verina T; Zhou Y; Alexander M; Pham L; Griswold M; Wong DF; Syversen T; Schneider JS J Neurochem; 2008 Dec; 107(5):1236-47. PubMed ID: 18808452 [TBL] [Abstract][Full Text] [Related]
12. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease. Marinova-Mutafchieva L; Sadeghian M; Broom L; Davis JB; Medhurst AD; Dexter DT J Neurochem; 2009 Aug; 110(3):966-75. PubMed ID: 19549006 [TBL] [Abstract][Full Text] [Related]
13. Manganese-Induced Parkinsonism Is Not Idiopathic Parkinson's Disease: Environmental and Genetic Evidence. Guilarte TR; Gonzales KK Toxicol Sci; 2015 Aug; 146(2):204-12. PubMed ID: 26220508 [TBL] [Abstract][Full Text] [Related]
14. Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones. Suárez F; Zhao Q; Monaghan DT; Jane DE; Jones S; Gibb AJ Eur J Neurosci; 2010 Aug; 32(3):359-67. PubMed ID: 20618827 [TBL] [Abstract][Full Text] [Related]
15. Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine. Rodrigues RW; Gomide VC; Chadi G Int J Neurosci; 2001 Jul; 109(1-2):91-126. PubMed ID: 11699344 [TBL] [Abstract][Full Text] [Related]
16. Chronic Manganese Administration with Longer Intervals Between Injections Produced Neurotoxicity and Hepatotoxicity in Rats. Fan XM; Luo Y; Cao YM; Xiong TW; Song S; Liu J; Fan QY Neurochem Res; 2020 Aug; 45(8):1941-1952. PubMed ID: 32488470 [TBL] [Abstract][Full Text] [Related]
17. Methylcyclopentadienyl Manganese Tricarbonyl Alter Behavior and Cause Ultrastructural Changes in the Substantia Nigra of Rats: Comparison with Inorganic Manganese Chloride. Zhu QF; Lu LL; Fang YY; Wu J; Huang ZY; Zheng XW; Song HX; Aschner M; Song C; Jiang YM Neurochem Res; 2022 Aug; 47(8):2198-2210. PubMed ID: 35513760 [TBL] [Abstract][Full Text] [Related]
18. Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats. Lu X; Bing G; Hagg T Neuroscience; 2000; 97(2):285-91. PubMed ID: 10799760 [TBL] [Abstract][Full Text] [Related]
19. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease. Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932 [TBL] [Abstract][Full Text] [Related]
20. 7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease. Lehéricy S; Bardinet E; Poupon C; Vidailhet M; François C Mov Disord; 2014 Nov; 29(13):1574-81. PubMed ID: 25308960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]